Categories Analysis, Earnings, Technology

Earnings preview: Mixed sentiment ahead of Oracle’s Q3 earning report

Software solutions provider Oracle Corp. (ORCL) will be reporting its third-quarter results on March 14 after the closing bell. The market predicts that earnings will edge up to $0.84 per share in the February quarter from $0.83 per share last year. The forecast for revenue is $9.6 billion, down 1.8% compared to the third quarter of 2018.

Oracle second quarter 2019 Earnings Infographic
Oracle Corp Q2 2019 Earnings Infographic

After ending the first half of the fiscal year on a positive note, the company had expressed optimism that the trend will continue in the rest of the year. The upbeat sentiment is justified to some extent by the rapid adoption of cloud-based ERP systems among enterprises and the growing demand for the Oracle Fusion ERP Cloud.

But market watchers are a bit skeptical as they see Oracle’s cloud business facing stiff competition from Amazon (AMZN) Web Services and Microsoft’s (MSFT) Azure, which continue to dominate the sector. As a result, margins will come under pressure from unfavorable pricing and higher costs associated with investments in infrastructure, adding to the ongoing squeeze on profitability from the faltering hardware business.

Margins will likely come under pressure from unfavorable pricing and higher costs associated with investments

Meanwhile, the management has a difficult task in hand – handling the various litigations related to business disputes, especially the one involving tech firm Rimini Street. Currently, analysts’ consensus rating on Oracle’s stock is hold and the average price target is $54.

In the second quarter, adjusted earnings grew 16% and topped expectations. At $9.56 billion, revenues were almost unchanged year-over-year but came in above the forecast. Of late, the company has been witnessing a steady increase in the number of customers, mainly for the NetSuite ERP service.

In January, Amazon Web Services reported a 45% growth in cloud revenues for its most recent quarter, driving total revenues and earnings higher by double-digit percentages. Among others, Salesforce (CRM) last week reported a 26% growth in revenues to $3.6 billion.

Oracle’s stock gained steadily over the years while the performance of its earnings per share remained subdued. The shares have maintained an uptrend since they bounced back from a multi-week low in December last year, gaining about 23%. Though the stock is currently hovering near the peak seen a year earlier, it continues to underperform the sector.

 

Earnings Call: Listen to on-demand earnings calls and hear how management responds to analysts’ questions

Most Popular

Agentforce in focus as Salesforce (CRM) gets ready for Q3 2025 earnings

After delivering mixed results in the first half, Salesforce, Inc. (NYSE: CRM) looks poised to report strong numbers when it publishes third-quarter results next week. The Customer relationship management platform

What to look for when Dollar Tree (DLTR) reports Q3 2024 earnings

Shares of Dollar Tree, Inc. (NASDAQ: DLTR) rose over 5% on Monday. The stock has dropped 27% over the past three months. The discount store chain is scheduled to report

Intensity Therapeutics is establishing a new field of localized cancer reduction: CEO

Intensity Therapeutics, Inc. (NASDAQ: INTS) is a clinical biotechnology company engaged in the discovery development, and commercialization of first-in-class cancer drugs that attenuate tumors with minimal side effects while training

Comments

  1. Pingback: this page
  2. Pingback: Locksmith Amory
  3. Pingback: APEX hacks
  4. Pingback: Schaduwdoeken
  5. Pingback: aksara178
  6. Pingback: yehyeh
  7. Pingback: buy nova cart
  8. Pingback: bonanza 178
  9. Pingback: snus
  10. Pingback: DataHK
  11. Pingback: amazing pharmacy
  12. Pingback: bonanza178
  13. Pingback: Scrunchies
  14. Pingback: Native Smokes
  15. Pingback: yehyeh.com
  16. Pingback: more
  17. Pingback: ks
  18. Pingback: hizeed
  19. Pingback: website
Add Comment
Loading...
Cancel
Viewing Highlight
Loading...
Highlight
Close
Top